List of members
Chairs:
- Finn Willingham, Head of ATTC Network Coordination, Cell and Gene Therapy Catapult
- Nick Meade, Director of Policy, Genetic Alliance UK
Public and Patient Voice Partners:
- Joanna Calder
- Stella O'Brien
- Laurence Woollard
Other member organisations (and roles of representatives):
- Adaptimmune (Director/Clinical Scientist)
- Advanced Therapies Wales (Project Manager)
- Anthony Nolan (Director of Patient Services)
- British Society for Gene and Cell Therapy (Board Member)
- Cardiff University (Research Fellow/Clinical Trials Manager, Reader in Neuropharmacology)
- Centre for Patient Reported Outcomes (Research Fellow/Deputy Director)
- Cell and Gene Therapy Catapult (ATTC Business Programme Manager)
- Cystic Fibrosis Trust (Senior Involvement Manager, CTAP Involvement Coordinator)
- EuroGCT (Project Manager, Information Officer)
- Genetic Alliance UK (Research Associate, Policy Analyst)
- Imperial College London (Manager of the Centre of Excellence for Advanced Therapeutics/Knowledge Exchange Practitioner London Advanced Therapies)
- Janssen (Patient Engagement & Advocacy Manager)
- Midlands and Wales Advanced Therapy Treatment Centre (MW-ATTC Programme Manager)
- Northern Alliance Advanced Therapies Treatment Centre (Lead Project Manager)
- NHS England (National Programme of Care Manager, National Senior Programme of Care Manager Innovative Treatments, Head of Commercial Medicines Policy Analysis, Public Engagement lead, Programme Support Manager)
- National Institute for Health and Care Research (Public Engagement and Involvement Manager, Senior Manager for Public Engagement and Involvement)
- Oxford Academic Health Science Network (Head of Clinical Innovation Adoption)
- The Christie NHS Foundation Trust
- Welsh Blood Service, Clinical Services (Head of Cell and Gene Therapy)
